Anika Therapeutics
ANIK
ANIK
108 hedge funds and large institutions have $191M invested in Anika Therapeutics in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 42 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
-1
Holders Change %
-0.92%
% of All Funds
1.47%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
33
Reduced
42
Closed
15
Calls
$33K
Puts
$23K
Net Calls
+$10K
Net Calls Change
-$6K
Top Buyers
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$5.94M |
| 2 |
CSC
Cove Street Capital
El Segundo,
California
|
+$1.13M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$960K |
| 4 |
Millennium Management
New York
|
+$782K |
| 5 |
Cerity Partners
New York
|
+$443K |
Top Sellers
| 1 |
AFA
Alta Fundamental Advisers
New York
|
-$3.45M |
| 2 |
Morgan Stanley
New York
|
-$967K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$822K |
| 4 |
JPMorgan Chase & Co
New York
|
-$682K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$652K |
